Fortis Healthcare Limited

INR 2,167

ugust 06, 2025 Fortis Healthcare announces Q1 FY26 Financial Results - Consolidated Revenues at INR 2,167 Cr, up 16.6%; Operating EBITDA Margin at 22.6% (vs Q1 FY25 at 18.4%) - Hospital Business Revenue

16.6%

Fortis Healthcare announces Q1 FY26 Financial Results - Consolidated Revenues at INR 2,167 Cr, up 16.6%; Operating EBITDA Margin at 22.6% (vs Q1 FY25 at 18.4%) - Hospital Business Revenues at INR 1,8

22.6%

6 Financial Results - Consolidated Revenues at INR 2,167 Cr, up 16.6%; Operating EBITDA Margin at 22.6% (vs Q1 FY25 at 18.4%) - Hospital Business Revenues at INR 1,838 Cr, up 18.6%; Operating EBITDA

18.4%

Consolidated Revenues at INR 2,167 Cr, up 16.6%; Operating EBITDA Margin at 22.6% (vs Q1 FY25 at 18.4%) - Hospital Business Revenues at INR 1,838 Cr, up 18.6%; Operating EBITDA margin at 22.1% (vs Q

INR 1,838

p 16.6%; Operating EBITDA Margin at 22.6% (vs Q1 FY25 at 18.4%) - Hospital Business Revenues at INR 1,838 Cr, up 18.6%; Operating EBITDA margin at 22.1% (vs Q1 FY25 at 18.5%) - Company further expands i

18.6%

g EBITDA Margin at 22.6% (vs Q1 FY25 at 18.4%) - Hospital Business Revenues at INR 1,838 Cr, up 18.6%; Operating EBITDA margin at 22.1% (vs Q1 FY25 at 18.5%) - Company further expands its footprint

22.1%

25 at 18.4%) - Hospital Business Revenues at INR 1,838 Cr, up 18.6%; Operating EBITDA margin at 22.1% (vs Q1 FY25 at 18.5%) - Company further expands its footprint in key metro cities with an O&M Ser

18.5%

ital Business Revenues at INR 1,838 Cr, up 18.6%; Operating EBITDA margin at 22.1% (vs Q1 FY25 at 18.5%) - Company further expands its footprint in key metro cities with an O&M Services agreement wit

26 %

the quarter ended June 30, 2025. Q1 Financial Highlights Consolidated (INR Cr) Q1 FY25 Q1 FY26 % Change YoY Q4 FY25 % Change QoQ Revenue 1,859 2,167 16.6% 2,007 7.9% Operating

25 %

2025. Q1 Financial Highlights Consolidated (INR Cr) Q1 FY25 Q1 FY26 % Change YoY Q4 FY25 % Change QoQ Revenue 1,859 2,167 16.6% 2,007 7.9% Operating EBITDA 343 491 43.2%

7.9%

Y25 Q1 FY26 % Change YoY Q4 FY25 % Change QoQ Revenue 1,859 2,167 16.6% 2,007 7.9% Operating EBITDA 343 491 43.2% 435 12.9% Operating EBITDA Margin 18.4% 22.6% 21

43.2%

5 % Change QoQ Revenue 1,859 2,167 16.6% 2,007 7.9% Operating EBITDA 343 491 43.2% 435 12.9% Operating EBITDA Margin 18.4% 22.6% 21.7% Profit After Tax after Minority I

“By attending or assessing this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.”

“This agreement will expand Fortis’ footprint in key metro cities.”

“Excluding one offs, the operating EBITDA margins stood at 18.7% in Q1 FY25.”

“25 PERFORMANCE REVIEW DIAGNOSTICS BUSINESS 26 DIAGNOSTICS BUSINESS • During Q1 FY26, Agilus conducted 10.13 Mn tests, versus 9.57 Mn in Q1 FY25, representing a growth of 5.8%.”

“• Agilus added 160+ Customer touchpoints* to its network in Q1 FY26.”

“• Agilus’ B2C: B2B revenue mix stood at 51:49 in the quarter vs 52:48 in Q1 FY25.”

“Excluding one offs, the operating EBITDA margins stood at 18.7% in Q1 FY25.”

Cash

2

For further details please contact

1

For further details please contact

Anurag Kalra / Amit Mahendru Investor Relations +91-9810109253 / +91-9891094323 Fortis Healthcare Limited Ajey Maharaj Corporate Communication +91-9871798573 Fortis Healthcare Limited 3 FORTIS HEALTHCARE LIMITED EARNINGS PRESENTATION – Q1 FY26 August 06, 2025 1 DISCLAIMER This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been prepared for informational purposes only. This presentation does not constitute a prospectus, offering circular or offering memorandum and is not an offer or invitation to buy or sell any securities, nor shall part, or all, of this presentation form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. Furthermore, this presentation is not and should not be construed as an o

Cash

Domestic, 33.6% Pvt Corps, 1.0% Govt & PSUs, 8.5% International , 7.8% CGHS, 4.7% ECHS, 7.7% Pvt Corps, 1.0% Govt & PSUs, 8.7% CGHS, 4.3% ECHS, 7.3% International , 7.9% 21 HOSPITAL BUSINESS PERFORMANCE – Q1FY26 All the key healthcare facilities continue to witness a YoY and QoQ upward momentum in revenues Revenue Q1FY25 Q1FY26 286 233 233 198 177 141 157 134 145 153 144 116 120 128 96 82 72 58 55 66 FMRI Mohali Shalimar Bagh Noida BG Road FEHI Mulund Anandpur Jaipur Faridabad Revenue Q4FY25 Q1FY26 286 262 233 203 172 177 157 140 146 153 135 144 125 128 95 96 72 53 60 66 FMRI Mohali Shalimar Bagh Noida BG Road FEHI Mulund Anandpur Jaipur Faridabad All figures in INR Cr. All figures in INR Cr. 22 HOSPITAL MARGIN MATRIX EBITDA No of Facilities Revenue Contribution Operational beds ARPOB (INR Cr) Occupancy >20% 15% - 20% 10% - 15% <10% 11 3 1 6^ 75.2% 12.4% 0.6% 10.7% 2,888 595 46 714 2.83 2.23 1.87 2.02 71% 74% 51% 58% ^ Note: <10% EBITDA Margin facilities include Ludhiana 2 (commissione